Clinical Trials Arena April 29, 2024
Affecting muscle and skeletal strength, this rare genetic disorder impacts thousands of men worldwide. Innovative new genetic therapies in development across the globe are improving the quality of life for many.
Impacting approximately 1 in 5,000 males globally, Duchenne Muscular Dystrophy is a rare genetic disorder characterised by progressive muscle weakness and skeletal degeneration. The prevalence of Duchenne Muscular Dystrophy is higher in certain regions, with Europe, particularly Sweden and Norway, along with the US, Canada, and China reporting elevated rates. This emphasises the considerable health burden associated with this condition, necessitating concerted efforts in research and treatment.
A new report from leading contract research organisation (CRO) Novotech dives deeper into the current clinical trials landscape and the status...
Today's Sponsors
Today's Sponsor